Pfizer Inc

Healthcare · Drug Manufacturers - General

28.20$ +0.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Pfizer Inc (PFE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 201,131 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PFE
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	215,021	226,501	221,095	216,193	219,476	213,396	208,028	206,095	208,731	208,160	207,618	201,131
Current Assets	74,012	43,333	42,415	37,825	43,223	50,358	45,861	43,703	46,924	42,898	42,822	41,358
Cash	3,148	2,853	719	1,052	1,092	1,043	1,430	1,638	1,343	1,142	1,703	976
Cash & Short-Term Investments	44,181	12,690	11,928	7,101	9,952	20,477	17,316	13,249	14,984	13,596	13,075	11,699
Receivables	15,003	11,177	10,989	15,087	17,694	14,777	14,745	16,094	18,115	15,841	12,585	12,490
Inventory	10,204	10,189	10,892	11,447	11,721	10,851	10,852	11,669	11,468	10,654	10,667	9,945
Property, Plant & Equipment	17,862	21,864	18,803	–	18,541	18,393	18,347	18,776	18,880	19,317	–	–
Goodwill	51,527	67,783	69,297	68,445	68,570	68,527	68,444	68,997	69,101	71,264	71,409	71,419
Intangible Assets	40,224	64,900	62,828	61,240	59,986	55,412	53,974	52,702	51,324	53,731	52,559	47,053
Total Liabilities	117,817	137,213	128,536	128,218	126,918	124,899	117,391	117,083	115,635	121,385	117,214	115,639
Current Liabilities	31,136	47,794	40,497	43,819	43,211	42,995	36,452	37,726	36,596	36,984	34,348	32,646
Short-Term Debt	2,548	10,877	8,232	11,944	9,699	6,946	4,471	4,295	4,303	3,484	3,890	2,699
Accounts Payable	5,338	6,710	5,591	5,106	5,314	5,633	5,240	5,166	5,024	5,240	4,506	4,581
Long-Term Debt	61,048	60,982	60,951	56,733	56,918	56,703	56,820	56,630	56,545	60,807	59,840	60,495
Shareholders' Equity	96,934	89,014	92,282	87,700	92,286	88,203	90,338	88,695	92,801	86,476	90,101	85,190
Retained Earnings	126,411	118,353	121,318	116,596	121,059	116,725	119,590	117,609	121,150	114,610	117,238	112,087
Shares Outstanding	5,646	5,647	5,697	5,696	5,705	5,703	5,710	5,706	5,714	5,686	5,731	5,699

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings